Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review-Reference-Cited by-同舟云学术

Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review

Published:2020-05 Issue:5 Volume:77 Page:614-627
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Moris Lisa,Cumberbatch Marcus G.,Van den Broeck Thomas,Gandaglia Giorgio,Fossati Nicola^ORCID,Kelly Brian,Pal Raj,Briers Erik,Cornford Philip,De Santis Maria,Fanti Stefano,Gillessen Silke,Grummet Jeremy P.,Henry Ann M.,Lam Thomas B.L.,Lardas Michael,Liew Matthew,Mason Malcolm D.,Omar Muhammad Imran,Rouvière Olivier,Schoots Ivo G.^ORCID,Tilki Derya,van den Bergh Roderick C.N.,van Der Kwast Theodorus H.,van Der Poel Henk G.,Willemse Peter-Paul M.,Yuan Cathy Y.^ORCID,Konety Badrinath,Dorff Tanya,Jain Suneil^ORCID,Mottet Nicolas,Wiegel Thomas

Publisher

Elsevier BV

Subject

Urology

Reference122 articles.

1. High-risk prostate cancer in the United States, 1990–2007;Cooperberg;World J Urol,2008

2. Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based study;Rider;Eur Urol,2013

3. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent;Mottet;Eur Urol,2017

4. Ten- and 15-yr Prostate Cancer-specific Mortality in Patients with Nonmetastatic Locally Advanced or Aggressive Intermediate Prostate Cancer, Randomized to Lifelong Endocrine Treatment Alone or Combined with Radiotherapy: Final Results of The Scandinavian Prostate Cancer Group-7

5. Final report of the intergroup randomized study of combined androgen-deprivation therapy plus radiotherapy versus androgen-deprivation therapy alone in locally advanced prostate cancer;Mason;J Clin Oncol,2015

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Worsening of 2-year patient-reported intestinal functionality after radiotherapy for prostate cancer including pelvic node irradiation;Radiotherapy and Oncology;2024-03

2. Tumor-associated macrophages and PD-L1 in prostate cancer: a possible key to unlocking immunotherapy efficacy;Aging;2024-01-04

3. Is there a role for radical prostatectomy in the management of oligometastatic prostate cancer? A systematic review;Prostate Cancer and Prostatic Diseases;2023-11-20

4. A US real-world study of treatment patterns and outcomes in localized or locally advanced prostate cancer patients;World Journal of Urology;2023-11-15

5. Risk factors for prostate-specific antigen persistence in pT3aN0 prostate cancer after robot-assisted laparoscopic radical prostatectomy: a retrospective study;Journal of Yeungnam Medical Science;2023-10-31